Found: 8
Select item for more details and to access through your institution.
Corrigendum: Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
- Published in:
- Nature Chemical Biology, 2014, v. 10, n. 8, p. 692, doi. 10.1038/nchembio0814-692d
- By:
- Publication type:
- Article
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology.
- Published in:
- Nature Chemical Biology, 2014, v. 10, n. 4, p. 305, doi. 10.1038/nchembio.1471
- By:
- Publication type:
- Article
Comprehensive analysis of kinase inhibitor selectivity.
- Published in:
- Nature Biotechnology, 2011, v. 29, n. 11, p. 1046, doi. 10.1038/nbt.1990
- By:
- Publication type:
- Article
A quantitative analysis of kinase inhibitor selectivity.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 1, p. 127, doi. 10.1038/nbt1358
- By:
- Publication type:
- Article
Response to Molecule–kinase interaction map.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Reply to BIRB-796 is not an effective ABL(T315I) inhibitor.
- Published in:
- 2005
- By:
- Publication type:
- Letter
A small molecule-kinase interaction map for clinical kinase inhibitors.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 3, p. 329, doi. 10.1038/nbt1068
- By:
- Publication type:
- Article
A CCHC metal-binding domain in Nanos is essential for translational regulation.
- Published in:
- EMBO Journal, 1997, v. 16, n. 4, p. 834, doi. 10.1093/emboj/16.4.834
- By:
- Publication type:
- Article